Related Experiment Videos
[Heart, brain and hypertension]
T F Lüscher1, M Sturzenegger, G Noll
1Abteilung für Kardiologie, Inselspital Bern.
Insights
Effective hypertension treatment significantly reduces stroke risk by 42%, highlighting the importance of blood pressure control. While cardiac event reduction is less pronounced, managing high blood pressure is crucial for overall cardiovascular health.
Area of Science:
- Cardiology
- Neurology
- Nephrology
Context:
- Hypertension is a primary risk factor for cardiovascular diseases, including stroke, coronary heart disease, and kidney failure.
- The risk of these complications escalates with rising blood pressure levels.
- Coexisting factors like hyperlipidemia, smoking, and diabetes exacerbate cardiovascular risk.
Purpose:
- To review the link between hypertension and cardiovascular complications.
- To discuss the efficacy of various antihypertensive therapies.
- To highlight the importance of sustained blood pressure management.
Summary:
- Antihypertensive medications such as diuretics, betablockers, ACE-inhibitors, and calcium antagonists effectively manage hypertension.
- Studies show antihypertensive therapy significantly reduces stroke by 42% but has a less pronounced effect on cardiac events (14%).
- The differential efficacy may stem from other contributing factors in coronary artery disease or differences in vascular reversibility.
Impact:
- Effective hypertension management is vital for preventing cerebrovascular events like stroke.
- Sustained blood pressure control is essential for mitigating overall cardiovascular morbidity and mortality.
- Further research is needed to understand the mechanisms behind the greater efficacy in preventing cerebral versus cardiac complications.
Abstract:
Hypertension is one of the most important cardiovascular risk factors. Without therapy hypertension leads to stroke, coronary heart disease with angina pectoris and myocardial infarction, kidney failure and/or peripheral vascular disease. The association between blood pressure and these cardiovascular complications can be demonstrated over the entire blood pressure range. The risk of stroke, myocardial infarction, renal failure or peripheral vascular disease increases with increasing blood pressure. Additional cardiovascular risk factors such as hyperlipidemia, smoking and diabetes involve a further increase in risk. Today hypertension can be effectively treated. To that end, diuretics, betablockers, ACE-inhibitors or calcium antagonists can be used. Alpha receptor antagonists and angiotensin AT1 receptor antagonists are also of value. The antihypertensive effectiveness of these drugs is comparable but may vary in individual patients. During antihypertensive therapy, a reduction in cerebrovascular and cardiac complications has been demonstrated for alpha methyldopa, diuretics and betablockers. In these studies, fatal and non-fatal strokes were reduced by 42%, while the reduction in cardiac events was less pronounced (14%). The reasons for this greater efficacy of antihypertensive therapy in the cerebral circulation are not clear. Other risk factors may be particularly important in the pathogenesis of coronary artery disease (e.g. genetic factors, hyperlipidemia and others) or hypertensive vascular changes in the coronary circulation may not be as reversible as they are in the cerebral circulation. The well documented correlation between stroke, myocardial infarction and hypertension, as well as the proven efficacy of antihypertensive therapy in preventing cardiovascular events, underscores the importance of effective and sustained blood pressure control in these patients.